Product Information
TUSNEL-EX 100 MG/5 ML LIQUID is a generic product labeled by Llorens Pharmaceutical International Division, priced at $0.0229 per ML under NDC 54859050704. Its NADAC has been published 206 times since Oct 26, 2022.
Strength
100 mg/5mL
Manufacturer
Llorens Pharmaceutical International DivisionNDC
54859050704
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
5/1/2019
Pharmacological Classes
Price Statistics
The NADAC for TUSNEL-EX 100 MG/5 ML LIQUID has been published 206 times since Oct 26, 2022, and over the history we have for it it has risen 52.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0229 per ML |
|---|---|
| All-time high | $0.0234 (Oct 16, 2024) |
| All-time low | $0.0125 (Sep 20, 2023) |
| 52-week high | $0.0229 |
| 52-week low | $0.0211 |
| Median price | $0.0215 |
| Average price | $0.0197 |
| Largest weekly change | +65.7% (Dec 20, 2023) |
| Weeks tracked | 206 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Llorens Pharmaceutical International Division manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TUSNEL-EX 100 MG/5 ML LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for TUSNEL-EX 100 MG/5 ML LIQUID, manufactured by Llorens Pharmaceutical International Division, is $0.0229 per ML (NDC 54859050704), effective Sep 30, 2026.
How has the price of TUSNEL-EX 100 MG/5 ML LIQUID changed over time?
Over the history we have for it, the NADAC for TUSNEL-EX 100 MG/5 ML LIQUID has risen 52.6%. It has been tracked across 206 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for TUSNEL-EX 100 MG/5 ML LIQUID?
Since Oct 26, 2022, the NADAC for TUSNEL-EX 100 MG/5 ML LIQUID has ranged from a low of $0.0125 (Sep 20, 2023) to a high of $0.0234 (Oct 16, 2024), with a median of $0.0215 per ML.
Are there cheaper alternatives to TUSNEL-EX 100 MG/5 ML LIQUID?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GUAIFENESIN 100 MG/5 ML SOLN, is $0.0110 per ML — about 52% below TUSNEL-EX 100 MG/5 ML LIQUID.
Who manufactures TUSNEL-EX 100 MG/5 ML LIQUID?
TUSNEL-EX 100 MG/5 ML LIQUID (NDC 54859050704) is labeled by Llorens Pharmaceutical International Division, and CMS classifies it as a generic product.